Despite its growth, NYSE:DOCS remains within the realm of affordability.

Here's DOXIMITY INC-CLASS A (NYSE:DOCS) for you, a growth stock our stock screener believes is undervalued. NYSE:DOCS is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. Let's break it down further.

Growth Analysis for NYSE:DOCS

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:DOCS has earned a 8 for growth:

• Measured over the past years, DOCS shows a very strong growth in Earnings Per Share. The EPS has been growing by 106.72% on average per year.
• DOCS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.65%.
• DOCS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.27% yearly.
• The Earnings Per Share is expected to grow by 24.26% on average over the next years. This is a very strong growth
• DOCS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.10% yearly.

Valuation Analysis for NYSE:DOCS

ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NYSE:DOCS, the assigned 5 reflects its valuation:

• 88.10% of the companies in the same industry are more expensive than DOCS, based on the Price/Earnings ratio.
• Based on the Price/Forward Earnings ratio, DOCS is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
• Based on the Enterprise Value to EBITDA ratio, DOCS is valued cheaper than 83.33% of the companies in the same industry.
• DOCS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DOCS is cheaper than 85.71% of the companies in the same industry.
• The excellent profitability rating of DOCS may justify a higher PE ratio.
• DOCS's earnings are expected to grow with 15.24% in the coming years. This may justify a more expensive valuation.

What does the Health looks like for NYSE:DOCS

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:DOCS has earned a 9 out of 10:

• An Altman-Z score of 19.50 indicates that DOCS is not in any danger for bankruptcy at the moment.
• DOCS has a better Altman-Z score (19.50) than 97.62% of its industry peers.
• DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
• A Current Ratio of 7.00 indicates that DOCS has no problem at all paying its short term obligations.
• DOCS's Current ratio of 7.00 is amongst the best of the industry. DOCS outperforms 88.10% of its industry peers.
• A Quick Ratio of 7.00 indicates that DOCS has no problem at all paying its short term obligations.
• DOCS's Quick ratio of 7.00 is amongst the best of the industry. DOCS outperforms 88.10% of its industry peers.

Analyzing Profitability Metrics

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:DOCS has earned a 9 out of 10:

• DOCS's Return On Assets of 12.01% is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.
• With an excellent Return On Equity value of 14.14%, DOCS belongs to the best of the industry, outperforming 97.62% of the companies in the same industry.
• DOCS has a better Return On Invested Capital (13.40%) than 100.00% of its industry peers.
• The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 4.22%.
• DOCS's Profit Margin of 27.48% is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.
• In the last couple of years the Profit Margin of DOCS has grown nicely.
• DOCS has a better Operating Margin (31.82%) than 100.00% of its industry peers.
• DOCS's Operating Margin has improved in the last couple of years.
• DOCS's Gross Margin of 88.14% is amongst the best of the industry. DOCS outperforms 97.62% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of DOCS

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.